Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Mini

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Journal of Inorganic Biochemistry|March 23, 2011
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligandLaura Maiore, Maria Agostina Cinellu, Elena Michelucci, et al.
Oncology Research|December 7, 2019
Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution ExperienceStefania Nobili, Daniele Lavacchi, Gabriele Perrone, et al.
Journal of Inorganic Biochemistry|November 13, 2012
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomicsFrancesca Guidi, Alessandra Modesti, Ida Landini, et al.
Dalton Transactions (Cambridge, England : 2003)|November 27, 2015
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivativesMaria Serratrice, Laura Maiore, Antonio Zucca, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2010
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancerOrazio Caffo, Stefania Fallani, Elena Marangon, et al.
Journal of Inorganic Biochemistry|March 21, 2026
Corrigendum to "The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics" J Inorg Biochem 2013 Jan:118:94-9. doi:10.1016/j.jinorgbio.2012.10.003. Epub 2012 Oct 14Francesca Guidi, Alessandra Modesti, Ida Landini, et al.
Inorganic Chemistry|February 21, 2012
Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivativesMaria Serratrice, Maria A Cinellu, Laura Maiore, et al.
Cancer Chemotherapy and Pharmacology|November 7, 2023
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?Martina Catalano, Andrea Lapucci, Stefania Nobili, et al.
Current Cancer Drug Targets|September 22, 2020
Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA StudyMartina Catalano, Giandomenico Roviello, Raffaele Conca, et al.
Cancers|December 24, 2021
Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal CancerZahra Pezeshkian, Stefania Nobili, Noshad Peyravian, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Journal of Inorganic Biochemistry|March 23, 2011
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligandLaura Maiore, Maria Agostina Cinellu, Elena Michelucci, et al.
Oncology Research|December 7, 2019
Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution ExperienceStefania Nobili, Daniele Lavacchi, Gabriele Perrone, et al.
Journal of Inorganic Biochemistry|November 13, 2012
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomicsFrancesca Guidi, Alessandra Modesti, Ida Landini, et al.
Dalton Transactions (Cambridge, England : 2003)|November 27, 2015
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivativesMaria Serratrice, Laura Maiore, Antonio Zucca, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2010
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancerOrazio Caffo, Stefania Fallani, Elena Marangon, et al.
Journal of Inorganic Biochemistry|March 21, 2026
Corrigendum to "The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics" J Inorg Biochem 2013 Jan:118:94-9. doi:10.1016/j.jinorgbio.2012.10.003. Epub 2012 Oct 14Francesca Guidi, Alessandra Modesti, Ida Landini, et al.
Inorganic Chemistry|February 21, 2012
Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivativesMaria Serratrice, Maria A Cinellu, Laura Maiore, et al.
Cancer Chemotherapy and Pharmacology|November 7, 2023
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?Martina Catalano, Andrea Lapucci, Stefania Nobili, et al.
Current Cancer Drug Targets|September 22, 2020
Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA StudyMartina Catalano, Giandomenico Roviello, Raffaele Conca, et al.
Cancers|December 24, 2021
Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal CancerZahra Pezeshkian, Stefania Nobili, Noshad Peyravian, et al.
Pageof 14